Stay Informed. Stay Competitive with FREE Insights on the Stock Market, Dow 30 & Emerging Opportunities. Get Free Email Updates

Stay Competitive With Stock Market Updates!

Get Free Updates

Fate Therapeutics, Inc. (FATE)

About

Here's What The Experts Are Saying

Scott Wolchko

Scott Wolchko

President and Chief Executive Officer

View LinkedIn

“While monoclonal antibodies are proven therapeutic agents that are often used early in the tr...

Read more

 

coming soon

Video's

Coming Soon

News Around The Web

Show More

Vista Exclusive Content

Fate Therapeutics Announces Completion of Public Offering of Common Stock At $28.31/share & Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jun 12, 2020

Fate Therapeutics Announces Completion of Public Offering of Common Stock At $28.31/share & Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read More
Fate Therapeutics (FATE) Hits New All-Time High During Investor Conference Schedule
Feb 21, 2020

Fate Therapeutics (FATE) Hits New All-Time High During Investor Conference Schedule

Read More
View All

Emerging Opportunities

Choose one of the above emerging opportunities to learn more today

View All

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us